Skip to main content

First Tracks Biotherapeutics, Inc 8-K, filed Oct 20, 2026

First Tracks Biotherapeutics, Inc. (TRAX)

8-K 2026-10-20 For: 2026-10-19
View Original
Added on October 20, 2026

About this 8-K

First Tracks Biotherapeutics, Inc filed this 8-K on October 20, 2026, reporting on events of October 19, 2026.

On October 19, 2026, First Tracks Biotherapeutics, Inc. closed a private placement of 6,106,870 common shares, par value $0.001 per share, and must file or confidentially submit a resale registration statement no later than 30 days after closing. AI summary

Items reported

  • Item 1.01: Entered into a material agreement
  • Item 9.01: Financial statements and exhibits